RUA Life Sciences plc (LON:RUA – Get Free Report)’s stock price reached a new 52-week high during trading on Monday . The stock traded as high as GBX 29.94 and last traded at GBX 28.46, with a volume of 211732 shares. The stock had previously closed at GBX 28.
RUA Life Sciences Stock Up 1.6%
The company has a debt-to-equity ratio of 18.95, a current ratio of 4.64 and a quick ratio of 7.32. The business’s fifty day moving average price is GBX 25.30 and its two-hundred day moving average price is GBX 20.10. The stock has a market capitalization of £17.66 million, a PE ratio of -2.61 and a beta of 0.99.
RUA Life Sciences (LON:RUA – Get Free Report) last issued its quarterly earnings results on Tuesday, June 30th. The company reported GBX (0.33) EPS for the quarter. RUA Life Sciences had a negative return on equity of 2.03% and a negative net margin of 3.26%.
RUA Life Sciences Company Profile
The RUA Life Sciences group was created in April 2020 when AorTech International plc acquired RUA Medical Devices Ltd to create a fully formed medical device business. RUA Life Sciences is the holding company of the group trading through four businesses all exploiting the group’s polymer technology. Our vision is to improve the lives of millions of patients by improving and enabling medical devices with Elast-EonTM, the worlds leading long term implantable polyurethane.
Featured Articles
- Five stocks we like better than RUA Life Sciences
- Institutional Money Is Pouring Into These 2 Altcoin ETFs
- The End of Big Tech Buybacks? Only One Hyperscaler Is Still Repurchasing Shares
- 3 Dividend Kings to Buy While They’re Still Beaten Down
- Rocket Lab Insiders Are Selling—But Institutions Keep Buying
Receive News & Ratings for RUA Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RUA Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
